March 2022

Department

Research in Review

Reviewing the Latest Research on Multiple Myeloma

03/16/2022

JCP Editors

03/16/2022

Journal of Clinical Pathways

Research in Review

Reviewing the Latest Research on Value-Based Care, Clinical Pathways, and Precision Medicine

03/16/2022

JCP Editors

03/16/2022

Journal of Clinical Pathways

Column

Clinical Pathways GPS

The Future of Medicare…Medicare Managed Care

03/16/2022

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Richard G Stefanacci, DO, MGH, MBA, explains why it is highly likely that Medicare managed care will represent over half of the Medicare market in the next year and, therefore, become a leader not only for Medicare care but also a guide for...

Richard G Stefanacci, DO, MGH,...

03/16/2022

Journal of Clinical Pathways

Trending From ACCC

Effective Practices in Multidisciplinary Hepatocellular Carcinoma Care

03/16/2022

Association of Community Cancer Centers

Authors from ACCC discuss managing patients with HCC in community cancer programs.

Authors from ACCC discuss...

03/16/2022

Journal of Clinical Pathways

Pharma Insights

The Patient and Consumer Experience—The Core and Progress Duality for Successful and Sustainable Transformation

03/16/2022

Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Cynthia Miller, MD, MPH

Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues propose a vision for the future of the patient/consumer experience to serve as a blueprint for organizations to develop and implement a strategy that is both effective and in alignment...

Elizabeth Oyekan, PharmD, FCSHP,...

03/16/2022

Journal of Clinical Pathways

Health Systems Insights

Setting Performance Expectations in Population Health Care Programs

03/16/2022

Joshua M Liao, MD, MSc

Joshua M Liao, MD, MSc suggests ways in which health systems leaders and organizations can calibrate care pathway program performance expectations to better understand true population health care initiative success.

Joshua M Liao, MD, MSc suggests...

03/16/2022

Journal of Clinical Pathways

Feature

From the Field

Incidence and Cost of Radical Prostatectomy and Radiotherapy for NCCN Low-risk Prostate Cancer in Utah

03/16/2022

David Gill, MD

Jessica Baumgartner

Jesse Gygi

McKenzie Bell

Libby Petersen

Bryan Crawford

Zoya Sandhu

Brandon Barney, MD

Jonathan Tward, MD

David Gill, MD , and colleagues analyzed rates of treatment for men with low-risk disease who were treated at either The Huntsman Cancer Institute or Intermountain Healthcare facilities, and modeled the costs associated with the presumptive...

David Gill, MD , and colleagues...

03/16/2022

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

March 2022

Department

Column

Feature

Current Issue

Special Reports

Subscribe

March 2022 Volume 8 Issue 2

Specialties

Events

Year Round Education

HMP Global Products